1.Expression of Fas ligand protein in human non-small cell lung cancer and its clinical significance
Yidan LIN ; Yaoguang JIANG ; Ruwen WANG
Journal of Third Military Medical University 2001;23(5):530-532
Objective To explore the expression of Fas ligan d (FasL) protein in human non-small cell lung cancer (NSCLC) and its clinic al significance. Methods Expression of FasL protein was detecte d by immunohistochemical method in 32 resected tumors of NSCLC. Results FasL protein was detected in all of these 32 resected tumors with variant pos itive expression levels ranging from 3.0% to 98.7% [mean (62.0±32.0)%]. T here wa s significant difference between the tumors of different pathological types no s ignificant difference was found between the tumors of different differentiation nor among the tumors of different pTNM stages (P>0.05). Conclusion The results indicated that NSCLC can counterattack the immune cells of t he body and may be the molecular basis for the easily metastasis of adenocarcino ma to in the early stage.
2.Determination of Matrine in Matrine Ethosome Thermosensitive Gels by HPLC
Zhengde HUANG ; Ruwen LIN ; Xiaoping LIU
Herald of Medicine 2016;35(5):521-523
Objective To establish an HPLC method for determination of matrine in matrine ethosome thermosensitive gels. Methods Matrine was detected in matrine ethosome thermosensitive gels by using a YMC-Pack NH2 column(4.6 mm× 150 mm,5 μm),with the mobile phase containing acetonitrile-ethanol(9: 1).The flow rate was 0.8 mL·min-1 ,the column temperature( 25 ± 2) ℃ and the UV detection wavelength 215 nm. Results The peak area correlated with matrine concentration within the range of 1.00-100.00 μg·mL-1 linearly,and the average correlation coefficient was 0.999 2.The average recoveries rate of low,medium and high concentration of matrine were 98.16%,98.15%,98.00%,respectively,and the RSD were 0.30%,0. 69%,0. 71%,respectively. Conclusion The method is simple,sensitive and accurate. With the advantages of specificity,high precision,good stability and repeatability,the HPLC method can be used for the determination of matrine in matrine ethosome thermosensitive gels.
3.Inhibition of lung cancer cells of primary culture and A549 cell line on the proliferation of tumor-infiltrating lymphocytes in vitro
Guoqiang ZHANG ; Yaoguang JIANG ; Ruwen WANG ; Yidan LIN
Journal of Third Military Medical University 1984;0(01):-
Objective To study the inhibition of lung cancer cells of primary culture and A549 cell line on the proliferation of tumor-infiltrating lymphocytes(TIL) in vitro and its clinical implications.Methods Human lung cancer cells and TILs were isolated from 8 cases of primary lung cancer and cultured.The inhibition of isolated human cancer cells and A549 cells to TILs was detected by MTT method.Results Lung cancer cells of primary culture and A549 cells can kill TILs to various degrees.Conclusion Inhibition of lung cancer cells to TIL may be one of the mechanisms of immune escapes.
4.Study on HLA-ABDR alleles in A549 and Calu-6 lung cancer cell lines with PCR-SSP.
Bo DENG ; Yidan LIN ; Ruwen WANG ; Yaoguang JIANG
Chinese Journal of Lung Cancer 2006;9(2):113-116
BACKGROUNDIt has been confirmed that human leucocyte antigen (HLA) may play very important roles in the process of antigen presenting and antigen distinguishing. HLA has a close relationship with the immunity killing and immunity escape in cancer. HLA-ABDR alleles were detected in A549 and Calu-6 lung cancer cell lines by PCR-sequence specific primers (PCR-SSP) in this research.
METHODSDNA of A549 and Calu-6 was purified and PCR-SSP was practiced. Then the gel was scanned in ultra-violet. HLA-A, HLA-B and HLA-DR were determined with special response list.
RESULTSHLA-A and HLA-B in A549 and Calu-6 were not integral, but HLA-DR was integral. The genotype of HLA-ABDR for A549 was: HLA-A30, HLA-B44, HLA-DR7/HLA-DR53. The genotype of HLA-ABDR for Calu-6 was: HLA-A01, HLA-B08, HLA-DR17/HLA-DR52.
CONCLUSIONSHuman adenocarcinoma cell line exists both HLA-I and HLA-II genotypes. Selective loss of HLA-I gene might be occured during tumor generation, but all the HLA-II genes remain. Detection of tumor HLA is necessary to the acknowledgment of tumor immunology behavior and foundation of tumor specific cytotoxic T lymphocyte.
5.Chinese consensus on surgical treatment of traumatic rib fractures (2021)
Lingwen KONG ; Guangbin HUANG ; Yunfeng YI ; Dingyuan DU ; Baoguo JIANG ; Jinmou GAO ; Lianyang ZHANG ; Jianxin JIANG ; Xiangjun BAI ; Tianbing WANG ; Xingji ZHAO ; Xingbo DANG ; Zhanfei LI ; Feng XU ; Zhongmin LIU ; Ruwen WANG ; Yingbin XIAO ; Qingchen WU ; Chun WU ; Liming CHENG ; Bin YU ; Shusen CUI ; Jinglan WU ; Gongliang DU ; Jin DENG ; Ping HU ; Jun YANG ; Xiaofeng YANG ; Jun ZENG ; Haidong WANG ; Jigang DAI ; Yong FU ; Lijun HOU ; Guiyou LIANG ; Yidan LIN ; Qunyou TAN ; Yan SHEN ; Peiyang HU ; Ning TAO ; Cheng WANG ; Dali WANG ; Xu WU ; Yongfu ZHONG ; Anyong YU ; Dongbo ZHU ; Renju XIAO ; Biao SHAO
Chinese Journal of Trauma 2021;37(10):865-875
Traumatic rib fractures are the most common injury in thoracic trauma. Previously,the patients with traumatic rib fractures were mostly treated non-surgically,of which 50%,especially those combined with flail chest presented chronic pain or chest wall deformities and over 30% had long-term disabilities,being unable to retain a full-time job. In the past two decades,thanks to the development of internal fixation material technology,the surgical treatment of rib fractures has achieved good outcomes. However,there are still some problems in clinical treatment,including inconsistency in surgical treatment and quality control in medical services. The current consensuses on the management of regional traumatic rib fractures published at home and abroad mainly focus on the guidance of the overall treatment decisions and plans,and relevant clinical guidelines abroad lacks progress in surgical treatment of rib fractures in recent years. Therefore,the Chinese Society of Traumatology affiliated to Chinese Medical Association and Chinese College of Trauma Surgeons affiliated to Chinese Medical Doctor Association,in conjunction with national multidisciplinary experts,formulate the Chinese Consensus for Surgical Treatment of Traumatic Rib Fractures(2021)following the principle of evidence-based medicine,scientific nature and practicality. This expert consensus puts forward some clear,applicable,and graded recommendations from aspects of preoperative imaging evaluation,surgical indications,timing of surgery,surgical methods,rib fracture sites for surgical fixation,internal fixation methods and material selections,treatment of combined injuries in rib fractures,in order to provide references for surgical treatment of traumatic rib fractures.